Board of Directors
Mr. Gladney has served as President and Chief Executive Officer since November 2015, and Chairman of the Board of Directors since October 2016. Mr. Gladney joined the Company in November 2015 as President-elect and a member of the board of directors. Prior to joining the Company, Mr. Gladney served as Chairman and Chief Executive Officer of Lanx, Inc., a medical device company focused on developing and commercializing innovative devices for spinal surgery. Prior to joining Lanx, Inc., Mr. Gladney was a Healthcare Operating Partner at Norwest Equity Partners (NEP), where he was responsible for strategic planning, business growth, and corporate governance for NEP portfolio companies, and executing new investment opportunities for the firm. Prior to joining NEP, Mr. Gladney served as President and Chief Executive Officer of several medical device companies including Heart Leaflet Technologies and ACIST Medical Systems, both of which were acquired by The Bracco Group. He also served as Chairman, Chief Executive Officer and President of Complex Technologies, a publicly traded orthopedic and health and wellness electro therapy company. Mr. Gladney currently serves on the Board of Directors of ARIA CV, Inc. and has been a member of a number of other private and public company boards. After the sale of Lanx, Inc., he acted as a private investor and small business consultant.
Mr. Tremmel has served as a director since January 2009. Mr. Tremmel has been retired and acting as an independent consultant since 2007. Over the course of his career at Medtronic, Inc., Mr. Tremmel served in a variety of senior management positions, including President of the Neurological Division, President of the Physio Control Division, President of the Tachyarrhythmia Management Division and President of the Interventional Vascular Division. Mr. Tremmel currently serves on the board of Cyberonics, Inc., a publicly held company that designs, develops, and markets implantable medical devices for the treatment of epilepsy and other debilitating neurological disorders, and Nuvectra Corp, a publically held neuromodulation medical device company focused on the development of neurostimulation technology to treat various disorders of the nervous systems.
Mr. Griffin has served as a director since September 2006. In 1998, Mr. Griffin retired from a 25-year career with Medtronic, Inc., where he held various positions, including Executive Vice President, and President of Medtronic’s pacemaker business. Since his retirement, Mr. Griffin has been a private investor, managing his own fund of companies as well as serving on the advisory boards of Affinity Capital Management Fund III and IV, and Sapient Capital Management Fund, in which he also invests. In addition, Mr. Griffin has served on the Board of Directors of several public companies, including MTS Systems Corporation and Urologix, Inc., and is currently a director of several private companies.
Ms. McDougal has served as a director since July 2015. With more than 18 years of experience in the healthcare industry at an executive level, she has also served as Executive Vice President at Optum, Inc., part of UnitedHealth Group, Inc. Prior to her time at Optum, she served as Chief Executive Officer of UnitedHealth Group’s subsidiary UnitedHealth Military & Veterans Services, LLC, and previously served as Chief Operating Officer of UnitedHealth Military & Veterans Services. Before joining UnitedHealth Military & Veterans Services, she served as a Vice President of UnitedHealthcare Medicare & Retirement. Additionally, she served as President of UnitedHealth International, and Vice President of OptumInsight.
Mr. Blackford has served a director since August 2016. Mr. Blackford has over 30 years of executive experience in the healthcare industry, having most recently served as President, Chief Executive Officer, and member of the Board of Directors of Universal Hospital Services Inc., a nationwide provider of medical equipment management, technology, and service solutions for the healthcare industry. From 2001 to 2002, Mr. Blackford was Chief Executive Officer of Curative Health Services, Inc., a specialty healthcare services and pharmacy distribution company. Mr. Blackford has also served in executive roles at pharmacy benefit management companies, including Medintell Systems Corporation, and ValueRx (acquired by Express Scripts). He currently serves as a member of the Board of Directors for Wright Medical Group N.V., Halyard Health, Inc., and PipelineRx.
Dr. Mashaal was elected to the Board in October 2017, in conjunction with acquisition of ReShape Medical, Inc. Dr. Mashaal is Managing Director and Founding Partner of HealthCor Partners Management, LP, a registered investment advisor that invests primarily in growth equity and later-stage development companies across all sectors of the healthcare and lifesciences industry. Dr. Mashaal joined HealthCor Group in 2005. From 2000 to 2005, Dr. Mashaal served as a research analyst focused on healthcare and biotechnology for several large investment banking firms. Dr. Mashaal graduated from Emory University with a B.A. in biology. He received his MD from the State University of New York at Stony Brook School of Medicine, and trained in general surgery at the University Hospital at Stony Brook.